ANN Prediction of Metabolic Syndrome: a Complex Puzzle that will be Completed

The diagnosis of metabolic syndrome (MetS) has a leading role in the early prevention of chronic disease, such as cardiovascular disease, type 2 diabetes, cancers and chronic kidney disease. It would be very greatful that MetS diagnosis can be predicted in everyday clinical practice. This paper presents artificial neural network (ANN) prediction of the diagnosis of MetS that includes solely non-invasive, low-cost and easily-obtained diagnostic methods. This solution can extract the risky persons and suggests complete tests only on them by saving money and time. ANN input vectors are very simple and contain solely non-invasive, low-cost and easily-obtained parameters: gender, age, body mass index, waist-to-height ratio, systolic and diastolic blood pressures. ANN output is MetS-coefficient in true/false form, obtained from MetS definition of International Diabetes Federation (IDF). ANN training, validation and testing are conducted on the large dataset that includes 2928 persons. Feed-forward ANNs with 1–100 hidden neurons were considered and an optimal architecture were determinated. Comparison with other authors leads to the conclusion that our solution achieves the highest positive predictive value PPV = 0.8579. Further, obtained negative predictive value NPV = 0.8319 is also high and close to PPV, which means that our ANN solution is suitable both for positive and negative MetS prediction.

[1]  V. Grujić,et al.  [Epidemiology of obesity in adult population of Vojvodina]. , 2005, Medicinski pregled.

[2]  Anoop Misra,et al.  Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. , 2003, Nutrition.

[3]  Aleksandar Kupusinac,et al.  Determination of WHtR Limit for Predicting Hyperglycemia in Obese Persons by Using Artificial Neural Networks , 2012 .

[4]  Toshifumi Hibi,et al.  Prediction of metabolic syndrome using artificial neural network system based on clinical data including insulin resistance index and serum adiponectin , 2011, Comput. Biol. Medicine.

[5]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[6]  Miguel Murguía-Romero,et al.  Predicting Metabolic Syndrome with Neural Networks , 2013, MICAI.

[7]  M. Ashwell,et al.  Waist‐to‐height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta‐analysis , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[8]  Sara Moein Medical Diagnosis Using Artificial Neural Networks , 2014 .

[9]  G. Lewicki,et al.  Approximation by Superpositions of a Sigmoidal Function , 2003 .

[10]  Chaoyang Li,et al.  Metabolic Syndrome and Incident Diabetes , 2008, Diabetes Care.

[11]  Edita Stokić,et al.  [Therapeutic options for treatment of cardiometabolic risk]. , 2009, Medicinski pregled.

[12]  Julia K Mader,et al.  Adipose tissue, inflammation and cardiovascular disease. , 2010, Revista da Associacao Medica Brasileira.

[13]  D Krewski,et al.  Metabolic syndrome and chronic disease. , 2014, Chronic diseases and injuries in Canada.

[14]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[15]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[16]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[17]  E. Stokic,et al.  Gender-, Age-, and BMI-Specific Threshold Values of Sagittal Abdominal Diameter Obtained by Artificial Neural Networks , 2015, Journal of Medical and Biological Engineering.

[18]  Who Consultation on Obesity Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.

[19]  Chao-Cheng Lin,et al.  Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models. , 2010, The Journal of clinical psychiatry.

[20]  Paolo Chiodini,et al.  Metabolic Syndrome and Risk of Cancer , 2012, Diabetes Care.

[21]  Hui Chen,et al.  Evaluating the Risk of Metabolic Syndrome Based on an Artificial Intelligence Model , 2014 .

[22]  Paul Zimmet,et al.  [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. , 2005, Revista espanola de cardiologia.

[23]  Richard W Grant,et al.  Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records , 2009, BMC health services research.